CA3076858A1 - Process for preparing a platelet lysate fraction, platelet lysate fraction and its use for treating disorders of the central nervous system - Google Patents

Process for preparing a platelet lysate fraction, platelet lysate fraction and its use for treating disorders of the central nervous system Download PDF

Info

Publication number
CA3076858A1
CA3076858A1 CA3076858A CA3076858A CA3076858A1 CA 3076858 A1 CA3076858 A1 CA 3076858A1 CA 3076858 A CA3076858 A CA 3076858A CA 3076858 A CA3076858 A CA 3076858A CA 3076858 A1 CA3076858 A1 CA 3076858A1
Authority
CA
Canada
Prior art keywords
platelet lysate
fraction
platelet
kda
lysate fraction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3076858A
Other languages
English (en)
French (fr)
Inventor
David DEVOS
Thierry Burnouf
Jean-christophe DEVEDJIAN
Ming-Li CHOU
Flore GOUEL
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Universitaire de Lille
Universite du Littoral Cote dOpale
Universite de Lille
Taipei Medical University TMU
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Centre Hospitalier Regional Universitaire de Lille CHRU
Universite du Littoral Cote dOpale
Universite de Lille
Taipei Medical University TMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM, Centre Hospitalier Regional Universitaire de Lille CHRU, Universite du Littoral Cote dOpale, Universite de Lille, Taipei Medical University TMU filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Publication of CA3076858A1 publication Critical patent/CA3076858A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/19—Platelets; Megacaryocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0644—Platelets; Megakaryocytes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
CA3076858A 2017-09-27 2018-09-27 Process for preparing a platelet lysate fraction, platelet lysate fraction and its use for treating disorders of the central nervous system Pending CA3076858A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17306284.5 2017-09-27
EP17306284 2017-09-27
PCT/EP2018/076244 WO2019063683A1 (en) 2017-09-27 2018-09-27 PROCESS FOR THE PREPARATION OF PLATELET LYSATE FRACTION, PLATELET LYSATE FRACTION AND USE THEREOF FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Publications (1)

Publication Number Publication Date
CA3076858A1 true CA3076858A1 (en) 2019-04-04

Family

ID=60083230

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3076858A Pending CA3076858A1 (en) 2017-09-27 2018-09-27 Process for preparing a platelet lysate fraction, platelet lysate fraction and its use for treating disorders of the central nervous system

Country Status (11)

Country Link
US (1) US20230135837A1 (enExample)
EP (1) EP3687554A1 (enExample)
JP (1) JP2020535163A (enExample)
CN (1) CN111107857A (enExample)
AU (1) AU2018343875A1 (enExample)
BR (1) BR112020006316A2 (enExample)
CA (1) CA3076858A1 (enExample)
IL (1) IL273482A (enExample)
RU (1) RU2020112898A (enExample)
TW (1) TW201914595A (enExample)
WO (1) WO2019063683A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108671224B (zh) * 2011-06-27 2022-12-13 爱默蕾大学 血小板裂解物的组合物、用途和制备
TWI744300B (zh) * 2016-03-23 2021-11-01 里爾中央醫學中心 改良性熱處理的血小板顆粒裂解液在製備用於治療神經系統疾病的組合物的用途
US20210236556A1 (en) * 2020-02-03 2021-08-05 Oklahoma Blood Institute Preparation of human platelet lysate (hpl) from refrigerated whole blood platelets
EP3881858A1 (en) * 2020-03-20 2021-09-22 Rok Pangersic Heat-treated platelet-derived growth factor extract for use in a method of preventing or treating a tissue defect

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4815063B2 (ja) * 2001-04-13 2011-11-16 きみ子 室伏 環状ホスファチジン酸を含むグリア細胞の増殖、分化及び／又は生存の促進のための薬剤
SE528214C2 (sv) * 2005-06-23 2006-09-26 Proliff Ab Förfarande för framställning av blodplättslysat
EP2101806B1 (en) * 2006-12-14 2013-05-01 NeuroNova AB Treatment of parkinson's disease or parkinsonian disorders using agents that decrease the activity of the melanocortin 4 receptor
EP2389942B1 (en) * 2010-05-25 2013-01-23 GwoWei Technology Co., Ltd. Virally-inactivated growth factors-containing platelet lysate depleted of PDGF and VEGF and preparation method thereof
US11285100B2 (en) * 2014-02-20 2022-03-29 Ortho Regenerative Technologies Inc. Freeze-dried polymer compositions for mixing with platelet rich plasma to form implants for tissue repair and/or compositions for therapeutic intra-articular injections
CA3138143A1 (en) * 2014-05-16 2015-11-19 Mayo Foundation For Medical Education And Research Cell culture media compositions for primary cells

Also Published As

Publication number Publication date
TW201914595A (zh) 2019-04-16
AU2018343875A1 (en) 2020-04-16
BR112020006316A2 (pt) 2020-09-24
RU2020112898A (ru) 2021-10-04
US20230135837A1 (en) 2023-05-04
JP2020535163A (ja) 2020-12-03
EP3687554A1 (en) 2020-08-05
IL273482A (en) 2020-05-31
WO2019063683A1 (en) 2019-04-04
CN111107857A (zh) 2020-05-05

Similar Documents

Publication Publication Date Title
US11744863B2 (en) Process for preparing a pooled human platelet lysate, pooled human platelet lysate and its use for treating neurological disorders
KR102805434B1 (ko) 성장 인자들 함유 혈소판 방출물을 제조하는 방법
US20230135837A1 (en) Process for preparing a platelet lysate fraction, platelet lysate fraction and its use for treating disorders of the central nervous system
AU2017238476B2 (en) Preparation of platelet pellet lysate and its use for treating neurological disorders
JP2016210730A (ja) 医薬組成物及びその製造方法並びに医薬品
RU2802440C2 (ru) Способ получения объединенного лизата тромбоцитов человека, объединенный лизат тромбоцитов человека и его применение для лечения неврологических нарушений
Jinbo et al. Olfactory ensheathing cell-conditioned medium protects astrocytes exposed to hydrogen peroxide stress
CN104208721B (zh) 一种携带Neuritin基因的慢病毒在制备修复视网膜色素上皮变性药物中的应用
TW200930726A (en) Clottable concentrate of platelet growth factors and preparation method thereof